CERTIFICATIONS

The vision of ΙΝΑΒ is to maintain the highest possible level of quality in the entire spectrum of its operations and services.
INAB has established a robust Integrated Information Security (IS) and Business Continuity (BC) Management System, certified according to ISO/IEC 27001:2013 and ISO 22301:2019 respectively. This system, diligently maintained since 2018, underscores INAB’s commitment to security, data protection and operational resilience.

INΑB has installed and implements a Quality Management System according to the ELOT EN ISO/IEC 15189:2012 Standard, the relevant documents of ESYD, as well as any other specifications related to the activities of the Laboratories. ΙΝΑΒ is committed to complying with the requirements of the above Standard and continuously improving its efficiency. The system is maintained since 2018.

The laboratories participate in external quality control schemes and are constantly updating their certificates as well as enriching their fields of accreditation with new ones. You can see here, the Institute’s “Table of Participation in external quality assessment schemes”.

PARTICIPATION IN EXTERNAL QUALITY ASSESSMENT SCHEMES

ORGANIZATION

SCHEME

Instand e.V

Molecular Oncology TP53

Detection of TP53 gene mutations (Sanger Sequencing)

GenQA-ERIC

TP53 Certification

Detection of TP53 gene mutations by next-generation sequencing

UK NEQAS

TCR Clonality Status

Determination of T cell receptor β chain gene rearrangements

UK NEQAS

IgH Clonality Status

Determination of mmunoglobulin heavy chain gene rearrangements

EMQN_ QCMD Quality Control for Molecular Diagnostics

SARS-CoV-2 EQA Programme

Molecular detection of the SARS-CoV-2 virus

EMQN_ QCMD Quality Control for Molecular Diagnostics

ONCOGENE_PANEL-22

Detection of mutations in hematologic malignancies

UK NEQAS

Chronic Lymphocytic mutation status_GenQA

Determination of IGHV gene somatic hypermutation status

EMQN_ QCMD Quality Control for Molecular Diagnostics

ONCOGENE_PANEL-22

Detection of mutations in solid tumors

ERIC, European Research Initiative on CLL

TP53 Certification

Detection of TP53 gene mutations by next-generation sequencing

ERIC, European Research Initiative on CLL

Chronic Lymphocytic Leukemia (CLL) IGHV mutation status

Determination of IGHV gene somatic hypermutation status

ORGANIZATION

SCHEME

ORGANIZATION

Instand e.V

SCHEME

Molecular Oncology TP53

Detection of TP53 gene mutations (Sanger Sequencing)

ORGANIZATION

GenQA-ERIC

SCHEME

TP53 Certification

Detection of TP53 gene mutations by next-generation sequencing

ORGANIZATION

UK NEQAS

SCHEME

TCR Clonality Status

Determination of T cell receptor β chain gene rearrangements

ORGANIZATION

UK NEQAS

SCHEME

IgH Clonality Status

Determination of mmunoglobulin heavy chain gene rearrangements

ORGANIZATION

EMQN_ QCMD Quality Control for Molecular Diagnostics

SCHEME

SARS-CoV-2 EQA Programme

Molecular detection of the SARS-CoV-2 virus

ORGANIZATION

EMQN_ QCMD Quality Control for Molecular Diagnostics

SCHEME

ONCOGENE_PANEL-22

Detection of mutations in hematologic malignancies

ORGANIZATION

UK NEQAS

SCHEME

Chronic Lymphocytic mutation status_GenQA

Determination of IGHV gene somatic hypermutation status

ORGANIZATION

EMQN_ QCMD Quality Control for Molecular Diagnostics

SCHEME

ONCOGENE_PANEL-22

Detection of mutations in solid tumors

ORGANIZATION

ERIC, European Research Initiative on CLL

SCHEME

TP53 Certification

Detection of TP53 gene mutations by next-generation sequencing

ORGANIZATION

ERIC, European Research Initiative on CLL

SCHEME

Chronic Lymphocytic Leukemia (CLL) IGHV mutation status

Determination of IGHV gene somatic hypermutation status